Cargando…
Human leishmaniasis vaccines: Use cases, target population and potential global demand
The development of vaccines against one or all forms of human leishmaniasis remains hampered by a paucity of investment, at least in part resulting from the lack of well-evidenced and agreed estimates of vaccine demand. Starting from the definition of 4 main use cases (prevention of visceral leishma...
Autores principales: | Malvolti, Stefano, Malhame, Melissa, Mantel, Carsten F., Le Rutte, Epke A., Kaye, Paul M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486101/ https://www.ncbi.nlm.nih.gov/pubmed/34547025 http://dx.doi.org/10.1371/journal.pntd.0009742 |
Ejemplares similares
-
Overcoming roadblocks in the development of vaccines for leishmaniasis
por: Kaye, Paul M., et al.
Publicado: (2021) -
The potential impact of human visceral leishmaniasis vaccines on population incidence
por: Le Rutte, Epke A., et al.
Publicado: (2020) -
Estimating the global demand curve for a leishmaniasis vaccine: A generalisable approach based on global burden of disease estimates
por: Mohan, Sakshi, et al.
Publicado: (2022) -
A Financial and Global Demand Analysis to Inform Decisions for Funding and Clinical Development of Group B Streptococcus Vaccines for Pregnant Women
por: Malvolti, Stefano, et al.
Publicado: (2021) -
Post-Kala-Azar Dermal Leishmaniasis as a Reservoir for Visceral Leishmaniasis Transmission
por: Le Rutte, Epke A., et al.
Publicado: (2019)